Akebia Therapeutics Inc. Stock Price (AKBA)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Onconova Therapeutics (ONTX) Investor Presentation - SlideshowThu, 21 Jan 2021 10:58:01 UTC via Seeking Alpha
Tenet Healthcare stock price target raised to $60 from $37 at UBSThu, 21 Jan 2021 09:58:58 UTC via MarketWatch
Prevail Therapeutics Shareholders Are Getting A Big Contingent Value RightThu, 21 Jan 2021 08:15:29 UTC via Seeking Alpha
Halozyme Therapeutics stock price target raised to $59 from $46 at BenchmarkThu, 21 Jan 2021 05:58:57 UTC via MarketWatch
Covetrus (CVET) Presents At 39th Annual J.P. Morgan Healthcare Conference - SlideshowWed, 20 Jan 2021 20:34:28 UTC via Seeking Alpha
Replimune (REPL) Presents At 39th Annual J.P. Morgan Healthcare Conference - SlideshowWed, 20 Jan 2021 20:34:09 UTC via Seeking Alpha
MiMedx Group (MDXG) Presents At 39th Annual J.P. Morgan Healthcare Conference - SlideshowWed, 20 Jan 2021 20:33:32 UTC via Seeking Alpha
Urogen Pharma (URGN) Presents At 39th Annual J.P. Morgan Healthcare Conference - SlideshowWed, 20 Jan 2021 20:33:17 UTC via Seeking Alpha
ChemoCentryx (CCXI) Presents At 39th Annual J.P. Morgan Healthcare Conference - SlideshowWed, 20 Jan 2021 20:31:23 UTC via Seeking Alpha
Y-mAbs Therapeutics (YMAB) Investor Presentation - SlideshowWed, 20 Jan 2021 20:30:29 UTC via Seeking Alpha

Akebia Therapeutics Inc. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:AKBA

You don't have any alerts set for IEX:AKBA.

About Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology.

CEOJohn P. Butler IndustryBiotechnology SectorHealthcare Websitehttp://www.akebia.com Issue ExchangeNASDAQ Global Market Issue TypeUnknown

Real-time AKBA to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.